Marimed (MRMD) Interest Expenses (2014 - 2026)

Marimed (MRMD) has 13 years of Interest Expenses data on file, last reported at $2.0 million in Q1 2026.

• Interest Expenses for Q1 2026 came in at $2.0 million, up 12.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.7 million (up 9.03% YoY), and the FY2025 annual result was $7.5 million, up 8.04% from the prior year.
• Interest Expenses fell to $2.0 million in Q1 2026 per MRMD's latest filing, from $2.2 million in the prior quarter.
• Over five years, Interest Expenses peaked at $2.6 million in Q2 2023 and troughed at $313000.0 in Q1 2022.
• A 5-year average of $1.6 million and a median of $1.8 million in 2025 frame the typical range for Interest Expenses.
• The sharpest annual moves came in 2023 and 2024: Interest Expenses jumped 700.32% in 2023, then slumped 34.97% in 2024.
• A 5-year view of Interest Expenses shows it stood at $422000.0 in 2022, then jumped by 269.19% to $1.6 million in 2023, then climbed by 21.05% to $1.9 million in 2024, then gained by 14.16% to $2.2 million in 2025, then dropped by 8.22% to $2.0 million in 2026.
• Business Quant data shows MRMD's Interest Expenses at $2.0 million in Q1 2026, $2.2 million in Q4 2025, and $1.8 million in Q3 2025.